S2 | E9 | AI-designed medicines to cure rare inherited disease with eMalick Njie - Founder @EcotoneAI
ThinkData Podcast · Dataworks Group Limited
Audio is streamed directly from the publisher (podcasts.captivate.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This is the ThinkData podcast in partnership with Dataworks, and in this episode, I spoke with EMalick Njie.
Emalick is the founder of Ecotone AI, a company with a very clear vision –
"To develop AI-based medicines that can cure approximately 10,000 inherited diseases that would have normally been overlooked by the pharmaceutical industry"
He has a fascinating backstory and is seen by many to be a true pioneer in this space.
We had a great discussion about the following:
✔His background and what led him to launch Ecotone
✔Who is Ecotone and what is their mission & vision?
✔What part AI plays in the product
✔What is an LGM(Large Genome Model)
✔The impact that AI can bring to medicine and rare genetic diseases
✔In a highly regulated space such as medicine, how EMalick and Ecotone navigate the various laws and policies in each state and country.
✔Emalick's thoughts on the current state of the generative AI market.
✔What can we expect to see from Ecotone over the coming months?
Click for a recent whitepaper EMalick released - https://emalick.substack.com/p/emergent-populations-derived-with